[Form 4] IonQ, Inc. Insider Trading Activity

Rhea-AI Filing Summary

IonQ insider grant: The filing shows Paul Dacier, Chief Legal Officer and Corporate Secretary of IonQ (IONQ), received a restricted stock unit award for 109,197 shares on 08/13/2025 at a reported price of $0. After the award, the reporting person beneficially owns 118,629 shares. The RSUs vest over three years with 1/12th of the total award vesting quarterly on March 10, June 10, September 10 and December 10, subject to continued service through each vesting date. The form is a routine Section 16 disclosure of an equity award to an officer and contains no other transactions or derivatives.

Insights

Corporate Governance Expert

TL;DR: Routine executive equity award to align officer incentives; standard multi-year vesting protects long-term shareholder interests.

The RSU grant to the CLO is a customary compensation tool that ties the officer's pay to share performance. Vesting quarterly over three years promotes retention and longer-term alignment with shareholders. The award appears to be an equity grant rather than a cash transaction, as the reported price is $0, and the filing discloses beneficial ownership after the grant. There is no indication of accelerated vesting, change-in-control provisions, or other atypical terms in the filing.

Securities Analyst

TL;DR: Non-cash RSU issuance increases share count potential modestly; disclosure is informational and not immediately market-moving.

The grant adds potential future dilution if shares vest and are issued, with 109,197 RSUs vesting over three years. The filing reports total post-transaction beneficial ownership of 118,629 shares for the reporting person, which helps quantify insider exposure. This single officer grant is routine and lacks accompanying transactions such as sales or option exercises that might be more relevant to short-term supply dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DACIER PAUL T

(Last) (First) (Middle)

C/O IONQ, INC

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO and Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		A		109,197(1)	A	$0	118,629	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest over three years, with 1/12th of the total number of shares underlying the award vesting quarterly on each March 10, June 10, September 10 and December 10, subject to the Reporting Person continuing as a service provider through each such vesting date.

	/s/ Kevin Caimi, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paul Dacier (IONQ) receive on 08/13/2025?

He received a restricted stock unit award of 109,197 RSUs reported at a price of $0.

How many IonQ shares does the reporting person own after the award?

The filing states the reporting person beneficially owns 118,629 shares following the transaction.

When do the RSUs vest?

The RSUs vest over three years with 1/12th of the award vesting quarterly on March 10, June 10, September 10 and December 10, subject to continued service.

Does the Form 4 show any sales or exercises by the reporting person?

No. The Form 4 reports only the RSU award; there are no sales, option exercises, or derivative transactions disclosed.

Is this grant likely to be materially market-moving?

The filing is a routine officer equity grant and the document provides no indication of market-moving conditions; it is informational.